CHMP: Positive evaluation of postoperative pain in exPAREL (Bubicain liposome suspension).

Pharmaceutical company Pacira BioSciences announced today that the European Medicines Agency's (EMA) Human Medicines Commission (CHMP) has a positive opinion on the treatment of postoperative pain in EXPAREL (Bubicain liposome suspension).
EXPAREL (Bubicain liposome suspension) blocks the plexus of the arms between the oblique muscles and is suitable for local analgesics in adults after surgery.
, CEO and Chairman of Pacira BioSciences, said, "CHMP's positive evaluation is an important milestone in innovative non-opioid pain management.
CHMP has made extensive recommendations for EXPAREL in various surgical environments and drug-giving techniques.
we look forward to the EMA's final decision and hope to have the opportunity to bring safe and effective alternatives to opioids to surgical patients in Europe."
bupivacaine is a local anaesthetic for aminoline.
AstraZeneca sells under several product names, including Marcain, Marcaine, Sensorcaine and Vivacaine.
is injected into surrounding tissue to block part of the nerve or injected into the spinal hole for epidural anesthesia.
have a ready-made dosage form mixed with epinephrine to achieve long-lasting effects;
.